Methazolamide
Methazolamide is an oral carbonic anhydrase inhibitor used to lower pressure inside the eye in certain types of glaucoma.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 12 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Methazolamide (Neptazane) is a glaucoma tablet that lowers eye pressure by blocking an enzyme, carbonic anhydrase, so the eye makes less fluid; it is usually an add-on when eye drops are not enough, has been on the market since about 1989, and is available as a generic. Side effects are common enough that some people stop it, mainly tingling in the hands and feet, tiredness, loss of appetite and taste changes. It is a sulfa drug, so stop it and call your doctor right away for any rash, unusual bruising or bleeding, or yellowing skin or eyes, and report rapid breathing or confusion too.
Clinical pearls
- Tell every prescriber if you take aspirin regularly, because high-dose aspirin with methazolamide has caused coma and death.
- Steroids such as prednisone raise the risk of low potassium, so expect blood tests for potassium and other salts.
- Mention any past sulfa allergy before starting, and never restart it after a serious skin, blood or liver reaction.
- Brief blurring of near vision and drowsiness can show up early, so hold off driving until you know how you react.
Patient information guide A plain-language walkthrough of Methazolamide, written from its FDA label.
What Methazolamide is used for
▾
Methazolamide tablets are prescribed to lower pressure inside the eye when that pressure reduction is expected to be beneficial. Supported uses include:
- Chronic open-angle glaucoma — the most common form of glaucoma, where eye pressure builds up gradually over time
- Secondary glaucoma — elevated eye pressure caused by another underlying condition
- Acute angle-closure glaucoma — used before surgery to bring eye pressure down ahead of the procedure
How Methazolamide works
▾
Methazolamide blocks an enzyme called carbonic anhydrase, which is involved in producing the clear fluid (aqueous humor) inside the eye. Less fluid production means less pressure build-up. Pressure typically starts falling within 2 to 4 hours, peaks around 6 to 8 hours after a dose, and the effect lasts 10 to 18 hours.
Although methazolamide is a sulfonamide derivative, it does not have meaningful antibiotic properties, and it is not used as a diuretic or seizure medication despite having mild effects in those areas.
Methazolamide dosage
▾
Methazolamide tablets are taken by mouth, usually two or three times a day. It may be taken alongside other glaucoma eye drops or agents your doctor prescribes. It takes about 7 days of regular dosing for the drug to reach a steady, consistent level in your body.
- Take each dose as directed by your prescriber — do not change your schedule without asking them first
- If you miss a dose, follow your prescriber's or pharmacist's guidance on what to do next
Dosing details from the FDA-approved label
From the Methazolamide prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Effective therapeutic dose (no specific condition named in the dosing text)
- 50 mg to 100 mg two or three times daily
- The drug may be used concomitantly with miotic and osmotic agents
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION: The effective therapeutic dose administered varies from 50 mg to 100 mg two or three times daily. The drug may be used concomitantly with miotic and osmotic agents.
Read the full Dosage and Administration section on DailyMed →
Methazolamide side effects
▾
Side effects tend to show up most often early in treatment. Common ones include:
Common side effects
- Tingling or "pins and needles" feeling in the hands and feet
- Fatigue or malaise
- Loss of appetite or taste changes
- Nausea, vomiting, or diarrhea
- Increased urination
- Drowsiness or confusion
- Ringing in the ears (tinnitus) or hearing changes
- Temporary blurred or worsened near vision (transient myopia)
- Fatigue, malaise, or feeling unwell
- Temporary worsening of near vision (transient myopia) — this usually clears once the dose is reduced or stopped
When to get medical help
- Get medical help right away if you develop a severe skin rash, blistering, or peeling — these can be signs of Stevens-Johnson syndrome or toxic epidermal necrolysis
- Call your doctor if you notice unusual bruising, bleeding, or signs of infection — these may point to a serious blood disorder such as aplastic anemia or agranulocytosis
- Seek care immediately for signs of liver problems: yellowing of the skin or eyes, severe nausea, or abdominal pain
- Tell your doctor if you develop rapid breathing, extreme tiredness, or confusion — these may signal a dangerous acid-base imbalance
- If you take high-dose aspirin, talk to your doctor right away if you experience poor appetite, rapid breathing, lethargy, or confusion
Methazolamide warnings and precautions
▾
- Serious skin and blood reactions: Rarely, methazolamide has caused life-threatening skin conditions (Stevens-Johnson syndrome, toxic epidermal necrolysis) and dangerous blood disorders (aplastic anemia, agranulocytosis). Stop the drug and seek care immediately if you develop a spreading rash, blistering, unusual bruising, or frequent infections.
- Liver damage: Serious liver reactions have occurred. Watch for yellowing of the skin or eyes, dark urine, or severe abdominal pain.
- High-dose aspirin interaction: Taking methazolamide with high-dose aspirin can cause loss of appetite, rapid breathing, extreme tiredness, coma, and death. Tell your doctor if aspirin is part of your regular regimen.
- Electrolyte and acid imbalances: Methazolamide can shift your body's mineral and acid-base balance. Your doctor may monitor your blood levels, especially potassium.
- Contraindicated conditions: Do not use this medication if you have low sodium or potassium levels, significant kidney or liver disease, adrenal failure, or a blood acid imbalance (hyperchloremic acidosis).
- Angle-closure glaucoma long-term use: Prolonged use is not appropriate for angle-closure glaucoma — it will not prevent permanent closure of the drainage angle in the eye.
Methazolamide interactions
▾
Methazolamide has two important drug interactions to know about:
- High-dose aspirin: This combination has been linked to very serious outcomes including coma and death. Tell every member of your care team if you take aspirin in any amount.
- Corticosteroids (steroid medications): Using steroids alongside methazolamide raises the risk of low potassium levels (hypokalemia), which can affect heart and muscle function. Your doctor may need to monitor your potassium.
Interactions listed in the FDA-approved label
From the Methazolamide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Steroid therapy: There is a potential for developing hypokalemia. Methazolamide should be used with caution in patients on steroid therapy.
- High-dose aspirin: Anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and carbonic anhydrase inhibitors. Caution is advised for patients receiving high-dose aspirin and methazolamide concomitantly (see WARNINGS).
Read the label’s full interactions text
Drug Interactions: Methazolamide should be used with caution in patients on steroid therapy because of the potential for developing hypokalemia. Caution is advised for patients receiving high-dose aspirin and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and carbonic anhydrase inhibitors (see WARNINGS ).
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Methazolamide
▾
- Tell your doctor if you have low sodium or potassium levels in your blood — methazolamide is contraindicated in these situations
- Do not take this medication if you have marked kidney or liver disease or dysfunction
- Avoid it if you have adrenal gland failure or a blood acid condition called hyperchloremic acidosis
- People with cirrhosis should not use it — it can trigger hepatic encephalopathy (a serious brain complication from liver disease)
- Do not use it long-term for angle-closure glaucoma — it will not stop the angle from closing permanently
- Tell your doctor about any prior allergic reaction to sulfonamide (sulfa) drugs — cross-reactions are possible
- Tell your prescriber about all medications you take, especially aspirin and steroids
Methazolamide overdose
▾
There are no reported cases of methazolamide overdose in humans. However, based on what is known, too much could cause electrolyte imbalances, increased acidity in the blood, and effects on the central nervous system. Treatment would focus on supportive care and monitoring blood electrolytes (especially potassium) and blood pH. There is no specific antidote — if you suspect an overdose, contact Poison Control or go to an emergency room.
What Methazolamide does in the body
▾
Methazolamide lowers the production of aqueous humor (the fluid inside the eye) by blocking carbonic anhydrase, reducing intraocular pressure. The pressure drop begins within 2 to 4 hours, peaks at 6 to 8 hours, and lasts 10 to 18 hours after a dose. It also has a mild, temporary diuretic effect — increasing urine output and causing excretion of sodium, potassium, and chloride — but it is not recommended or effective as a diuretic medication.
How your body processes Methazolamide
▾
Methazolamide is well absorbed after oral dosing, with peak blood levels reached 1 to 2 hours after taking a tablet. About 55% of the drug binds to proteins in the blood. It has a half-life of roughly 14 hours, meaning it takes about that long for half the drug to leave your system. About 25% is excreted unchanged in the urine over each dosing interval, and it takes approximately 7 days of regular dosing to reach a stable, steady level in the body.
How to store Methazolamide
▾
Store at 20°C to 25°C (68°F to 77°F). Dispense in a tight container as defined in the USP, with a child-resistant closure (as required).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Methazolamide
218 supplements and herbal products have documented interactions with Methazolamide in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 7
- Moderate · 187
- Minor · 24
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Methazolamide has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 2
- Moderate · 2
- Unrated · 3
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Methazolamide: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Methazolamide — the kind of thing our pharmacy team would talk through with you at the counter.
What is methazolamide actually doing for my eyes?
▾
What side effects should I actually expect when I start taking it?
▾
Are there any side effects I should treat as an emergency?
▾
I take aspirin every day. Is that a problem?
▾
Are there people who absolutely shouldn't take this medication?
▾
How long does it take for methazolamide to really kick in and stabilize?
▾
Is Methazolamide available over the counter?
▾
When was Methazolamide first available?
▾
Who makes Methazolamide?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Methazolamide on HelloPharmacist
Methazolamide forms and strengths (how it comes)
Methazolamide is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Methazolamide tablets are used to lower intraocular pressure in chronic open-angle glaucoma
- Methazolamide tablets are used in secondary glaucoma to reduce eye pressure
- Methazolamide tablets are used before surgery in acute angle-closure glaucoma to lower eye pressure
- Methazolamide tablets are taken by mouth two or three times daily as directed by your prescriber
- Methazolamide tablets may be used together with other glaucoma medications such as miotics or osmotic agents
- Follow your prescriber's instructions carefully — do not adjust your dose on your own
Methazolamide on the U.S. market: products, makers and brands
How Methazolamide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
9 companies list 20 Methazolamide product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1959. Brand names on the directory include Neptazane; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (9) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Methazolamide is used (Medicaid data)
A general measure of how commonly Methazolamide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Methazolamide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Methazolamide prescribed? Of the 1,601 medications we measure, Methazolamide ranks #1,081 by Medicaid prescriptions — more than 32% of them.
Utilization by Methazolamide product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
methazolamide 50 MG Oral Tablet Most dispensed
Summed across the 5 of 25 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197940
methazolamide 25 MG Oral Tablet
Summed across the 4 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197939
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Methazolamide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 9 of 48 listed Methazolamide NDCs with Medicaid activity.
Compare Methazolamide products
A representative set of FDA-listed product records for Methazolamide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 25 mg | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 50 mg | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 25 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 50 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 25 mg | Oral | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 50 mg | Oral | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 25 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 25 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| 50 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| 25 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 50 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 25 mg | Oral | Padagis US LLC | ANDA | View NDC → |
| 50 mg | Oral | Padagis US LLC | ANDA | View NDC → |
| 25 mg | Oral | Precision Dose, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Precision Dose, Inc. | ANDA | View NDC → |
Showing 20 of 20 products — FDA National Drug Code Directory. See every product, package size and price: browse all 20 Methazolamide NDCs →
Methazolamide side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Methazolamide — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Methazolamide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Methazolamide FDA approval history
How Methazolamide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Methazolamide recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Methazolamide recalls since July 2021.
✅No Methazolamide recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 6826 1 dose form · 2 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 372815In current FDA listings
Look up RxCUI 6826 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Methazolamide supply and shortage status
Whether Methazolamide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Methazolamide costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 25 mg | $0.627 per tablet | NDC details & price history |
| Tablet · Oral | 50 mg | $1.51 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Methazolamide brand names
Methazolamide is sold under one brand name in the FDA directory — Neptazane. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Methazolamide: manufacturers and labelers
9 companies list Methazolamide products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, ANI Pharmaceuticals, Inc., Ajanta Pharma USA Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Methazolamide drug class (RxNorm)
Methazolamide belongs to the Carbonic anhydrase inhibitors class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Methazolamide page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Precision Dose, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →